AMENDMENT NO. 1 TO COLLABORATION AND CO-PROMOTION AGREEMENTCollaboration and Co-Promotion Agreement • August 6th, 2007 • Medarex Inc • Services-commercial physical & biological research
THIS AGREEMENT (“Amendment”) is made and entered into effective as of April 25, 2007 (the “Amendment Effective Date”) by and between Medarex, Inc., a New Jersey corporation having its principal place of business at 707 State Road, Princeton, New Jersey 08540-1437 (“Medarex”) and Bristol-Myers Squibb Company, a Delaware corporation headquartered at 345 Park Avenue, New York, New York 10154 (“BMS”), and amends the COLLABORATION AND CO-PROMOTION AGREEMENT (the “Agreement”) made as of November 7, 2004 between Medarex and BMS. Medarex and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
COLLABORATION AND CO-PROMOTION AGREEMENT by and between MEDAREX, INC. and BRISTOL-MYERS SQUIBB COMPANY November 7, 2004Collaboration and Co-Promotion Agreement • January 24th, 2005 • Medarex Inc • Services-commercial physical & biological research • New York
THIS COLLABORATION AND CO-PROMOTION AGREEMENT (the “Agreement”) is made as of November 7, 2004 (the “Execution Date”), by and between Medarex, Inc., a New Jersey corporation having its principal place of business at 707 State Road, Princeton, New Jersey 08540-1437 (“Medarex”) and Bristol-Myers Squibb Company, a Delaware corporation headquartered at 345 Park Avenue, New York, New York 10154 (“BMS”), effective as of the Effective Date, except for Section 10.11, which shall be effective as of the Execution Date. Medarex and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
